Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CH.1.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.10.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.10.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.10.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.10.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EF.1.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EF.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EK.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.23.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.23.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.23.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.64ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.64ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.64ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.64NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.68ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.68ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.68NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.65 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.65 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.65 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.65 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.466ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used